PushButton AI Team ·

The AI tools collecting dust in your business aren't a failure of your judgment. They're a failure of how AI gets sold. Europe just committed $154 million to AI in a single niche — antibody discovery
The AI tools collecting dust in your business aren't a failure of your judgment. They're a failure of how AI gets sold.
Europe just committed $154 million to AI in a single niche — antibody discovery. Not "AI in general." One specific problem, one focused application, measurable outcomes.
That's the lesson most business owners never get told.
The consultants and vendors pitch you on AI as a category. Buy this platform, transform your business. But the industries actually winning with AI right now — pharma, logistics, finance — aren't buying platforms. They're solving one precise, painful, expensive problem and proving ROI before expanding.
Your $200/month tool isn't failing because AI doesn't work. It's failing because nobody scoped it to one real problem your team actually has.
Here's what to do this week: Write down the single most repetitive, time-consuming task in your business. One task. Then ask whether AI could handle just that — nothing else.
That's your starting point. Not a platform. Not a transformation. One task, one win, thirty days.
Which specific task would you most want off your plate if you knew AI could handle it reliably?
#AIStrategy #BusinessGrowth #SmallBusiness #AIImplementation
Europe's $154+ Million AI in Antibody Discovery Market, 2025-2035: Precision Therapies and AI Integration Spur Market Transformation. Research and ...